ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Sanofi to license multiple myeloma target domain from Eureka and MSK
July 08, 2021Sanofi has signed a licence agreement with Eureka Therapeutics and Memorial Sloan Kettering Cancer Center (MSK) for non-CAR use of a new human binding domain for the potential treatment of multiple myeloma. -
Actinium Initiates Patient Enrollment in Iomab-ACT Trial
April 01, 2021Actinium Pharmaceuticals announced its collaborator, Memorial Sloan Kettering Cancer Center (MSK), has commenced patient enrollment in the Phase 1 study evaluating Iomab-ACT for targeted conditioning prior to treatment with MSK's CD19 targeted ... -
Common cancer treatments do not worsen COVID-19 infection, study finds
June 30, 2020A study has found that chemotherapy and surgery do not correlate with worse COVID-19 outcomes for cancer patients, whereas taking immune checkpoint inhibitors does. -
Takeda strikes three new immuno-oncology deals
January 07, 2019Takeda is upping its commitment to cancer after its Shire takeover with the announcement of three new research collaborations in immuno-oncology..... -
Takeda announces multiple cell therapy collaborations
January 04, 2019New collaborations expand Takeda’s commitment to pursue the discovery of novel cell therapy approaches to treat blood cancers and solid tumors.
Pharma Sources Insight January 2025
